New England Journal of Medicine
March 2, 2017 Vol. 376 No. 9
Conflicts of Interest for Patient-Advocacy Organizations
M.S. McCoy and Others
In this examination of 104 large patient-advocacy organizations, 83% receive financial support from drug, device, and biotechnology companies, and industry executives often serve on governing boards. The authors recommend more transparency about industry involvement.